临床试验

Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

NCT：NCT05557123 · COMPLETED

NCT编号NCT05557123

状态COMPLETED

开始日期2022-03-10

完成时间2025-12-16

SponsorSeoul National University Bundang Hospital (OTHER)

First posted2022-09-27

Last updated2026-05-19

简要摘要

RIVOX-AF study is a prospective, multicenter, randomized controlled study in which patients with AF are allocated to medication-app group or conventional treatment group. The App based feed-back algorithm will provide the patients with check taking drug or reminding of taking drug.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。